Status:
COMPLETED
Prevalence of Fabry's Disease in a Population of Patients With Chronic Pains
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Pain
Fabry's Disease
Eligibility:
All Genders
6-65 years
Phase:
NA
Brief Summary
Fabry disease (FD) is a rare X-linked multisytemic lysosomal disorder caused by alpha-galactosidase deficiency. Globotriaosylcéramide (Gb3) deposits are observed in almost all tissues examined. Signs ...
Eligibility Criteria
Inclusion
- patients of both sex
- aged from 6 to 65
- with chronic pains of unknown aetiology including:
- acroparesthesias
- and/or pain crises evolving more than 3 months
- continued neuropathic evolving more than 3 months
- and/or multiple pains evolving more than 3 months
- and/or recurrent abdominal crises of pain who come for a clinical visit in the Centre Douleurs Chroniques in the CHU of Bordeaux.
Exclusion
- chronic pain of known cause
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
137 Patients enrolled
Trial Details
Trial ID
NCT01178164
Start Date
September 1 2010
End Date
September 1 2012
Last Update
April 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Douleurs Chroniques, Hopital Pellegrin
Bordeaux, France, 33076